Atlas Trials

Central Texas Neurology Consultants

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Central Texas Neurology Consultants

RecordFirmDate
Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients (NCT01333358)Central Texas Neurology Consultants2011-05-01

Track Central Texas Neurology Consultants automatically

Every clearance here is in the API, with alerts when new ones post.